-
1
-
-
16344362182
-
Outcome of endovascular treatment in symptomatic intracranial vascular stenosis
-
Suh DC, Kim SJ, Lee DH, et al. Outcome of endovascular treatment in symptomatic intracranial vascular stenosis. Korean J Radiol 2005;6:1-7
-
(2005)
Korean J Radiol
, vol.6
, pp. 1-7
-
-
Suh, D.C.1
Kim, S.J.2
Lee, D.H.3
-
2
-
-
33745780138
-
Neuroform in-stent stenosis: Incidence, natural history, and treatment strategies
-
Fiorella D, Albuquerque FC, Woo H, et al. Neuroform in-stent stenosis: incidence, natural history, and treatment strategies. Neurosurgery 2006;59:34-42
-
(2006)
Neurosurgery
, vol.59
, pp. 34-42
-
-
Fiorella, D.1
Albuquerque, F.C.2
Woo, H.3
-
3
-
-
2542580323
-
Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): Study results
-
SSYLVIA Study Investigators, Epub Apr 22
-
SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388 -92. Epub 2004 Apr 22.
-
(2004)
Stroke 2004;35:1388 -92
-
-
-
4
-
-
33745965540
-
Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events
-
Ries T, Buhk JH, Kucinski T, et al. Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006;37:1816-21
-
(2006)
Stroke
, vol.37
, pp. 1816-1821
-
-
Ries, T.1
Buhk, J.H.2
Kucinski, T.3
-
5
-
-
33645754725
-
Endovascular treatment of unruptured intracranial aneurysms: Occurrence of thromboembolic events
-
Grunwald IQ, Papanagiotou P, Politi M, et al. Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events. Neurosurgery 2006;58:612-18
-
(2006)
Neurosurgery
, vol.58
, pp. 612-618
-
-
Grunwald, I.Q.1
Papanagiotou, P.2
Politi, M.3
-
6
-
-
7844220998
-
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The full anticoagulation versus aspirin and ticlopidine (fantastic) study
-
Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation 1998;98:1597-603
-
(1998)
Circulation
, vol.98
, pp. 1597-1603
-
-
Bertrand, M.E.1
Legrand, V.2
Boland, J.3
-
7
-
-
0034691260
-
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
-
Cadroy Y, Bossavy JP, Thalamas C, et al. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000;101:2823-28
-
(2000)
Circulation
, vol.101
, pp. 2823-2828
-
-
Cadroy, Y.1
Bossavy, J.P.2
Thalamas, C.3
-
8
-
-
12844278540
-
Oral antiplatelet therapy and percutaneous coronary intervention
-
Yan BP, Clark DJ, Ajani AE. Oral antiplatelet therapy and percutaneous coronary intervention. Expert Opin Pharmacother 2005;6:3-12
-
(2005)
Expert Opin Pharmacother
, vol.6
, pp. 3-12
-
-
Yan, B.P.1
Clark, D.J.2
Ajani, A.E.3
-
9
-
-
0033806824
-
Stent thrombosis: Historical perspectives and current trends
-
Cutlip DE. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis 2000;10:89-101
-
(2000)
J Thromb Thrombolysis
, vol.10
, pp. 89-101
-
-
Cutlip, D.E.1
-
10
-
-
33749438519
-
Aspirin and clopidogrel resistance: Consideration and management
-
Gurbel PA, Tantry US. Aspirin and clopidogrel resistance: consideration and management. J Interv Cardiol 2006;19:439-48
-
(2006)
J Interv Cardiol
, vol.19
, pp. 439-448
-
-
Gurbel, P.A.1
Tantry, U.S.2
-
11
-
-
11844256436
-
Variability in platelet responsiveness to clopidogrel among 544 individuals
-
Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-51
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 246-251
-
-
Serebruany, V.L.1
Steinhubl, S.R.2
Berger, P.B.3
-
12
-
-
33947328091
-
Thienopyridines in cardiovascular disease: Focus on clopidogrel resistance
-
Siller-Matula J, Schror K, Wojta J, et al. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thromb Haemost 2007;97:385-93
-
(2007)
Thromb Haemost
, vol.97
, pp. 385-393
-
-
Siller-Matula, J.1
Schror, K.2
Wojta, J.3
-
13
-
-
33646441600
-
Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness
-
von Beckerath N, Pogatsa-Murray G, Wieczorek A, et al. Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost 2006;95:910-11
-
(2006)
Thromb Haemost
, vol.95
, pp. 910-911
-
-
von Beckerath, N.1
Pogatsa-Murray, G.2
Wieczorek, A.3
-
14
-
-
33750083316
-
A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention
-
Epub Aug 28
-
van Werkum JW, van der Stelt CA, Seesing TH, et al. A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention. J Thromb Haemost 2006;4:2516 -18. Epub 2006 Aug 28
-
(2006)
J Thromb Haemost 2006;4:2516 -18
-
-
van Werkum, J.W.1
van der Stelt, C.A.2
Seesing, T.H.3
-
15
-
-
33845474736
-
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
-
Epub Mar 24
-
Malinin A, Pokov A, Spergling M, et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res 2007;119:277-84. Epub 2006 Mar 24
-
(2006)
Thromb Res 2007
, vol.119
, pp. 277-284
-
-
Malinin, A.1
Pokov, A.2
Spergling, M.3
-
16
-
-
84989198039
-
Determination of individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASA system
-
Coleman JL, Wang JC, Simon DI. Determination of individual response to aspirin therapy using the accumetrics Ultegra RPFA-ASA system. Point of Care 2004;3:77-82
-
(2004)
Point of Care
, vol.3
, pp. 77-82
-
-
Coleman, J.L.1
Wang, J.C.2
Simon, D.I.3
-
17
-
-
2942555599
-
Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer
-
Malinin A, Spergling M, Muhlestein B, et al. Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis 2004;15:295-301
-
(2004)
Blood Coagul Fibrinolysis
, vol.15
, pp. 295-301
-
-
Malinin, A.1
Spergling, M.2
Muhlestein, B.3
-
18
-
-
9644281092
-
Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting
-
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 2005;115:101-08
-
(2005)
Thromb Res
, vol.115
, pp. 101-108
-
-
Angiolillo, D.J.1
Fernandez-Ortiz, A.2
Bernardo, E.3
-
19
-
-
4644289299
-
-
Chest
-
Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects - the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl 3):234S-64S
-
(2004)
Platelet-active drugs: The relationships among dose, effectiveness, and side effects - the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
, vol.126
, Issue.SUPPL. 3
-
-
Patrono, C.1
Coller, B.2
FitzGerald, G.A.3
-
21
-
-
0035908781
-
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
-
Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33
-
(2001)
Lancet
, vol.358
, pp. 527-533
-
-
Mehta, S.R.1
Yusuf, S.2
Peters, R.J.3
-
22
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann, J.T.3
-
23
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
-
24
-
-
18144371221
-
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting
-
Gurbel PA, Bliden KP, Hayes KM, et al. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 2005;45:1392-96
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1392-1396
-
-
Gurbel, P.A.1
Bliden, K.P.2
Hayes, K.M.3
-
25
-
-
33751078322
-
Clopidogrel response variability, resistance, or both?
-
Wiviott SD. Clopidogrel response variability, resistance, or both? Am J Cardiol 2006;98:18N-24N
-
(2006)
Am J Cardiol
, vol.98
-
-
Wiviott, S.D.1
-
26
-
-
34248397644
-
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days
-
von Beckerath N, Kastrati A, Wieczorek A, et al. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J 2007;28:1814-19
-
(2007)
Eur Heart J
, vol.28
, pp. 1814-1819
-
-
von Beckerath, N.1
Kastrati, A.2
Wieczorek, A.3
-
27
-
-
36148983750
-
-
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. Epub 2007 Nov 4
-
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15. Epub 2007 Nov 4
-
-
-
-
28
-
-
33645052218
-
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention)
-
Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-286
-
(2006)
Circulation
, vol.113
-
-
Smith Jr, S.C.1
Feldman, T.E.2
Hirshfeld Jr, J.W.3
-
29
-
-
34447282174
-
Clopidogrel resistance: Role of body mass and concomitant medications
-
Feher G, Koltai K, Alkonyi B, et al. Clopidogrel resistance: role of body mass and concomitant medications. Int J Cardiol 2006;120:188-92
-
(2006)
Int J Cardiol
, vol.120
, pp. 188-192
-
-
Feher, G.1
Koltai, K.2
Alkonyi, B.3
-
30
-
-
0038649988
-
Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
-
Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13
-
(2003)
Circulation
, vol.107
, pp. 2908-2913
-
-
Gurbel, P.A.1
Bliden, K.P.2
Hiatt, B.L.3
-
31
-
-
19644372173
-
Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention
-
Hochholzer W, Trenk D, Frundi D, et al. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 2005;111:2560-64
-
(2005)
Circulation
, vol.111
, pp. 2560-2564
-
-
Hochholzer, W.1
Trenk, D.2
Frundi, D.3
|